ELB.XETRA elumeo SE
- Market cap
- EUR 15.3M
- P/E
- -
- P/B
- 11.80x
- ROE
- -226.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is ELB.XETRA undervalued?
Graham numberThe Graham number of elumeo SE cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
elumeo SE fundamental analysis
No fundamental analysis for elumeo SE yet.
elumeo SE stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About elumeo SE
elumeo SE, through its subsidiaries, engages in the design, procurement, and distribution of gemstone jewelry. It offers various jewelry, jewelry goods, precious stones, and related products under the Juwelo, AMAYANI, and Jooli brand names. The company sells its products through electronic distribution channels, such as television, Internet, smart TV, and smartphone apps, as well as operates home shopping television (TV) stations and web shops in Germany, Great Britain, Ital…
Full company profileelumeo SE financial statements
elumeo SE annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 71.5M | 67.6M | 51.1M | 44.1M | 42.4M | 50.7M | 45.8M | 45.4M | 43.4M | 39.1M |
| Gross Profit | 31.2M | 29.8M | 13.5M | 20.6M | 22.2M | 28.9M | 25.2M | 22.7M | 20.4M | 18.7M |
| Operating Income | -13.5M | -1.60M | -18.0M | -2.05M | 168K | 1.98M | -887K | -2.96M | -3.36M | -2.51M |
| EBITDA | -7.46M | -8.32M | -17.5M | -1.15M | 634K | 2.93M | -463K | -1.96M | -2.52M | -1.90M |
| Net Income | -15.5M | -2.14M | -20.5M | -2.59M | 154K | 9.29M | -3.29M | -1.10M | -4.42M | -2.94M |
| EPS | -2.82 | -0.39 | -3.73 | -0.47 | 0.03 | 1.68 | -0.60 | -0.20 | -0.77 | -0.50 |
| Balance Sheet | ||||||||||
| Total Assets | 62.1M | 54.7M | 28.8M | 21.6M | 21.2M | 27.9M | 23.3M | 22.2M | 18.5M | 16.0M |
| Total Liabilities | 23.1M | 22.8M | 22.2M | 17.5M | 16.8M | 14.2M | 12.1M | 14.1M | 14.4M | 14.8M |
| Shareholders' Equity | 39.0M | 32.0M | 6.68M | 4.12M | 4.35M | 13.7M | 11.2M | 8.07M | 4.10M | 1.30M |
| Cash & Short-term Investments | 1.84M | 1.51M | 2.61M | 880K | 2.31M | 2.76M | 1.41M | 1.34M | 1.66M | 1.64M |
| Total Debt | 13.7M | 11.5M | 2.25M | 3.36M | 3.30M | 2.26M | 2.48M | 3.29M | 3.49M | 3.21M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -9.92M | 1.98M | -706K | 784K | 2.43M | 1.19M | -1.42M | -94.0K | -128K | 405K |
| Capital Expenditure | 1.03M | 231K | 453K | 178K | 223K | 355K | 59.0K | 16.0K | 79.0K | 28.0K |
| Free Cash Flow | -11.0M | 1.74M | -1.16M | 606K | 2.21M | 835K | -1.48M | -110K | -207K | 377K |
| Ratios | ||||||||||
| ROE | -39.8% | -6.7% | -306.9% | -62.8% | 3.5% | 67.7% | -29.5% | -13.7% | -107.9% | -226.6% |
| ROA | -25.0% | -3.9% | -71.1% | -12.0% | 0.7% | 33.3% | -14.1% | -5.0% | -23.8% | -18.3% |
| Net Profit Margin | -21.7% | -3.2% | -40.1% | -5.9% | 0.4% | 18.3% | -7.2% | -2.4% | -10.2% | -7.5% |
| Debt to Equity | 0.35x | 0.36x | 0.34x | 0.82x | 0.76x | 0.16x | 0.22x | 0.41x | 0.85x | 2.47x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
elumeo SE dividends
elumeo SE has not paid dividends in the last 10 fiscal years.
Who owns elumeo SE
- Insiders 36.84%
- Institutions 38.64%
- Public & others 24.52%
- Shares outstanding 6.78M
- Free float 4.43M
elumeo SE company profile
- Company name
- elumeo SE
- Ticker
- ELB.XETRA
- ISIN
- DE000A11Q059
- Exchange
- XETRA Stock Exchange
- Sector
- Consumer Cyclical
- Industry
- Textiles, Apparel & Luxury Goods
- Employees
- 163
- Fiscal year end
- December
- Address
- Erkelenzdamm 59/61, Berlin, Germany, 10999
- Phone
- 49 30 69 59 79 231
- Website
- elumeo.com
About elumeo SE
elumeo SE, through its subsidiaries, engages in the design, procurement, and distribution of gemstone jewelry. It offers various jewelry, jewelry goods, precious stones, and related products under the Juwelo, AMAYANI, and Jooli brand names. The company sells its products through electronic distribution channels, such as television, Internet, smart TV, and smartphone apps, as well as operates home shopping television (TV) stations and web shops in Germany, Great Britain, Italy, France, the Netherlands, Spain and Belgium. The company was formerly known as Atrium 66. Europäische VV SE and changed its name to elumeo SE in July 2014. elumeo SE was founded in 2008 and is headquartered in Berlin, Germany.
elumeo SE management
5- Mr. Florian SpatzMD & CEO · born 1990
- Mr. Wolfgang BoyeChairman of Executive Board · born 1969
- Dr. Susanne RiesDeputy Chair of Executive Board · born 1975
- Mr. Boris KirnCOO, MD & Member of Executive Board · born 1969
- Mr. Christian SenitzMember of the Executive Board · born 1978